Lenox Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$11K Hold
227
﹤0.01% 426
2020
Q1
$9K Sell
227
-305
-57% -$14.6K ﹤0.01% 408
2019
Q4
$27K Hold
532
0.01% 329
2019
Q3
$24K Sell
532
-23
-4% -$992 0.01% 332
2019
Q2
$24K Sell
555
-5
-0.9% -$213 0.01% 324
2019
Q1
$25K Buy
560
+27
+5% +$1.16K 0.01% 325
2018
Q4
$23K Sell
533
-125
-19% -$5.51K 0.01% 276
2018
Q3
$16K Buy
658
+458
+229% +$19.6K ﹤0.01% 357
2018
Q2
$8K Buy
+200
New +$7.87K ﹤0.01% 392

Other funds holding SNY

Lenox Wealth Management's SNY Position: Q2 2020 in Review

Lenox Wealth Management held its Sanofi (SNY) position steady in Q2 2020 at 227 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #426.

Lenox Wealth Management first reported a position in SNY in Q2 2018 and has held it in 9 quarters since. The position peaked at $27K in Q4 2019. 583 funds tracked by Wall St. Rank hold SNY as of Q2 2020.

  • Lenox Wealth Management held 227 shares of Sanofi worth $11K as of Q2 2020.
  • Lenox Wealth Management left its Sanofi share count unchanged in Q2 2020.
  • Sanofi made up ﹤0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #426 holding.
  • Lenox Wealth Management first reported a position in Sanofi in Q2 2018 and has held it in 9 quarters since.
  • Lenox Wealth Management's Sanofi position peaked at $27K in Q4 2019.
  • 583 funds tracked by Wall St. Rank held Sanofi as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.